RxSight, Inc. 8-K

What Happened

• RxSight, Inc. filed a Form 8-K (Item 5.02) reporting executive changes. On December 18, 2025, the Board appointed Eric Weinberg to the executive officer role of Chief Business Development Officer concurrent with his move from Chief Commercial Officer. On the same date, the Board appointed Scott Gaines as an executive officer serving as Chief Customer Officer, responsible for the company’s U.S. commercial organization. The report was signed and filed on December 19, 2025 by CEO Ron Kurtz, M.D.

Key Details

• Filing: Form 8-K (Item 5.02) filed December 19, 2025.
• Effective date of appointments: December 18, 2025.
• Eric Weinberg: moved from Chief Commercial Officer to Chief Business Development Officer.
• Scott Gaines: appointed Chief Customer Officer, overseeing U.S. commercial organization.

Why It Matters

• These leadership changes affect RxSight’s commercial and business development leadership—areas directly tied to sales strategy and customer operations in the U.S. For investors, shifts in executive roles can signal a refocus of priorities or changes in how the company plans to drive revenue and customer engagement, but the filing reports only the appointments and contains no commentary on compensation, strategic rationale, or expected financial impact.